gip/glp-1 Potential Use of GLP-1 and Receptor Agonists for Respiratory Disorders: Where Are We at? Frontiers | Clinical perspectives on

GLP-1 receptor agonists work by replicating the function of natural GLP-1, helping to restore these deficiencies

The risk of death among people with diabetes (aged 2059 years) is at least double that in those without diabetes [2]

Activation of GLP-1 receptors on vascular smooth muscle cells reduces the autoregulatory response in afferent arterioles and increases renal blood flow

The goal of a GLP-1 is sustainable weight loss and the improvement of overall metabolic health, including blood sugar, blood pressure, and cholesterol

This workflow ensures that members who need these medications can access them while maintaining appropriate utilization control

Because of this, your clinician might suggest waiting before evaluating results, so the medication has time to reach its full effect